Nigeria has declared interest to be part of the global Coronavirus drug trials, this was revealed by the World Health Organisation (WHO). The WHO says that the process will soon be initiated.
The officer in charge of WHO Nigeria, Fiona Braka, said over 100 countries have joined the solidarity clinical trial while not less than 1,200 Coronavirus patients have been randomized from the first five countries to examine the safety and effectiveness of the trial drugs.
Braka also disclosed at a press conference on Friday May 1, that at least 89 vaccines are being developed globally, including seven in the clinical tryout and various medication in clinical trials.
She said; “Nigeria has shown its interest to be part of the solidarity trials and efforts are been geared towards starting the process in Nigeria too. “In conjunction with global health partakers and partners, over the past weeks, WHO has launched the access to Coronavirus tools ACT accelerator, a global collaboration that will accelerate the development for equitable access to the new COVID-19 diagnostics, vaccines and medications.
“A total of 89 vaccines globally that are in progress, including seven in clinical evaluation and several medications that are in clinical trials. The WHO is committed to ensuring that vaccines and drugs are developed and shared equally among the countries and people.
However, not less than 100 countries have enrolled in the solidarity Covid-19 drug trial with over 1,200 patients being randomized from the first five countries to evaluate the safety and efficacy of full medication and drug combinations.”
As part of plans to fight the Coronavirus pandemic, the global health organization had launched drug trials, such as chloroquine phosphate, hydroxychloroquine, and remdesivirs in early April.